Brief: Vaccitech Reports First Quarter 2023 Financial Results
May 12 (Reuters) - Vaccitech PLC VACC.O :
* VACCITECH REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS AND
RECENT CORPORATE DEVELOPMENTS
* VACCITECH PLC Q1 REVENUE $500,000
* VACCITECH PLC - EXPECT OUR CASH RUNWAY TO FUND OUR
OPERATING
EXPENSES AND CAPITAL EXPENDITURE REQUIREMENTS INTO Q1 OF 2025
* VACCITECH PLC - AS OF MARCH 31, 2023, CASH WAS $191.3
MILLION,
COMPARED TO $194.4 MILLION AS OF DECEMBER 31, 2022
* VACCITECH PLC - QTRLY LOSS PER SHARE $0.48
Source text for Eikon: ID:nGNX4pmmcb
Further company coverage: VACC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Barinthus Biotherapeutics
See all newsBrief: Barinthus Bio Provides Update On Proposed Combination With Clywedog Therapeutics
Brief: Barinthus Biotherapeutics PLC Appoints Douglas Swirsky As CFO And Principal Accounting Officer Effective May 1, 2026
Brief: Barinthus Bio Announces Update On Phase 1 AVALON Clinical Trial Of VTP-1000 For The Treatment Of Celiac Disease
Brief: Barinthus Bio Reports Second Quarter 2025 Financial Results And Updates On Corporate Developments
Gemma Brown Terminated As CFO Effective April 30, 2025 - SEC Filing